Longbio Pharma, a leading biotech company focused on autoimmune and rare diseases, will attend the 6th BFC Annual Global Healthcare Business Development and Investment Conference ("BFC Conference") on Sunday, January 8 (Pacific Standard Time, "PST") at St. Regis San Francisco during the 41th JP Morgan Healthcare Conference.
It is a great honor to present and share the new progress about the company and leading pipeline in the BFC Conference. Document of the presentation will also be posted on the website of Longbio Pharma (www.longbio.com) for up to 30 days following the meeting.
Presentation of Longbio will begin at 15:00 (PST).
2023.01.06
